Ovid Therapeutics Inc. (OVID)

Ovid Therapeutics Statistics

Total Valuation

OVID has a market cap or net worth of $91.02 million. The enterprise value is $66.77 million.

Market Cap	91.02M
Enterprise Value	66.77M

Important Dates

The last earnings date was Wednesday, August 13, 2025, before market open.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

OVID has 71.11 million shares outstanding. The number of shares has increased by 0.43% in one year.

Current Share Class	71.11M
Shares Outstanding	71.11M
Shares Change (YoY)	+0.43%
Shares Change (QoQ)	+0.09%
Owned by Insiders (%)	5.70%
Owned by Institutions (%)	34.36%
Float	59.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.67
Forward PS	196.84
PB Ratio	1.63
P/TBV Ratio	1.63
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	10.04
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.72, with a Debt / Equity ratio of 0.25.

Current Ratio	4.72
Quick Ratio	4.30
Debt / Equity	0.25
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-28.95

Financial Efficiency

Return on equity (ROE) is -52.77% and return on invested capital (ROIC) is -29.98%.

Return on Equity (ROE)	-52.77%
Return on Assets (ROA)	-26.71%
Return on Invested Capital (ROIC)	-29.98%
Return on Capital Employed (ROCE)	-60.98%
Revenue Per Employee	$289,174
Profits Per Employee	-$1.63M
Employee Count	23
Asset Turnover	0.07
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	0.21
52-Week Price Change	n/a
50-Day Moving Average	0.61
200-Day Moving Average	0.61
Relative Strength Index (RSI)	86.10
Average Volume (20 Days)	1,840,068

Short Selling Information

The latest short interest is 1.51 million, so 2.12% of the outstanding shares have been sold short.

Short Interest	1.51M
Short Previous Month	1.61M
Short % of Shares Out	2.12%
Short % of Float	2.54%
Short Ratio (days to cover)	0.56

Income Statement

In the last 12 months, OVID had revenue of $6.65 million and -$37.52 million in losses. Loss per share was -$0.54.

Revenue	6.65M
Gross Profit	6.65M
Operating Income	-41.77M
Pretax Income	-50.68M
Net Income	-37.52M
EBITDA	-41.21M
EBIT	-41.77M
Loss Per Share	-$0.54

Balance Sheet

The company has $38.35 million in cash and $14.10 million in debt, giving a net cash position of $24.25 million or $0.34 per share.

Cash & Cash Equivalents	38.35M
Total Debt	14.10M
Net Cash	24.25M
Net Cash Per Share	$0.34
Equity (Book Value)	55.79M
Book Value Per Share	0.78
Working Capital	33.17M

Cash Flow

In the last 12 months, operating cash flow was -$40.07 million and capital expenditures -$18,000, giving a free cash flow of -$40.09 million.

Operating Cash Flow	-40.07M
Capital Expenditures	-18,000
Free Cash Flow	-40.09M
FCF Per Share	-$0.56

Margins

Gross Margin	100.00%
Operating Margin	-628.09%
Pretax Margin	-574.02%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

OVID does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.43%
Shareholder Yield	-0.43%
Earnings Yield	-41.22%
FCF Yield	-44.04%

Analyst Forecast

The average price target for OVID is $3.13, which is 144.53% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$3.13
Price Target Difference	144.53%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	94.77%
EPS Growth Forecast (5Y)	23.22%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

OVID has an Altman Z-Score of -5.42 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.42
Piotroski F-Score	1